SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 66 filers reported holding SYNERON MEDICAL LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $940,000 | +70.6% | 85,807 | +64.3% | 0.00% | – |
| Q1 2017 | $551,000 | +85.5% | 52,213 | +47.9% | 0.00% | – |
| Q4 2016 | $297,000 | +262.2% | 35,303 | +207.0% | 0.00% | – |
| Q3 2016 | $82,000 | -26.1% | 11,500 | -20.6% | 0.00% | – |
| Q2 2016 | $111,000 | +44.2% | 14,489 | +38.1% | 0.00% | – |
| Q1 2016 | $77,000 | -11.5% | 10,490 | -7.3% | 0.00% | – |
| Q4 2015 | $87,000 | -75.4% | 11,312 | -77.1% | 0.00% | – |
| Q3 2015 | $353,000 | -44.1% | 49,311 | -17.0% | 0.00% | – |
| Q2 2015 | $631,000 | +296.9% | 59,385 | +363.5% | 0.00% | – |
| Q1 2015 | $159,000 | -36.7% | 12,812 | -55.5% | 0.00% | – |
| Q2 2013 | $251,000 | +17.8% | 28,818 | +17.4% | 0.00% | – |
| Q4 2012 | $213,000 | -19.0% | 24,539 | -9.1% | 0.00% | – |
| Q3 2012 | $263,000 | -7.4% | 27,007 | -1.2% | 0.00% | – |
| Q2 2012 | $284,000 | +59.6% | 27,345 | +64.9% | 0.00% | – |
| Q1 2012 | $178,000 | – | 16,583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |